Industry: Healthcare
Published Date: May-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 188
Report ID: PMRREP34496
1. Executive Summary
1.1. Global Pulmonary Embolism Market Snapshot, 2024 and 2031
1.2. Market Opportunity Assessment, 2024 - 2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.3.3. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Product Adoption Analysis
3.2. Disease Epidemiology
3.3. Technology Assessment
3.4. Regulatory Landscape
3.5. Supply Chain Analysis
3.6. Key Deals and Mergers
3.7. PESTLE Analysis
3.8. Porter's Five Force Analysis
4. Price Analysis, 2023A
4.1. Key Highlights
4.2. Key Factors Impacting Product Prices
4.3. Pricing Analysis, By Product
4.4. Regional Prices and Product Preferences
5. Global Pulmonary Embolism Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
5.1. Key Highlights
5.1.1. Market Volume (Units) Projections
5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
5.1.3. Absolute $ Opportunity
5.2. Market Size (US$ Mn) Analysis and Forecast
5.2.1. Historical Market Size (US$ Mn) Analysis, 2018-2022
5.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2023-2031
5.3. Global Pulmonary Embolism Market Outlook: Product
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2018 - 2022
5.3.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2023 - 2031
5.3.3.1. Catheter-Directed Thrombolysis Devices
5.3.3.2. Mechanical Thrombectomy Devices
5.3.3.2.1. Thrombus Fragmentation Devices
5.3.3.2.2. Aspiration Thrombectomy Devices
5.3.3.2.3. Rheolytic Thrombectomy Devices
5.3.3.2.4. Others
5.3.3.3. Others
5.4. Market Attractiveness Analysis: Product
5.5. Global Pulmonary Embolism Market Outlook: End User
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2018 - 2022
5.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
5.5.3.1. Hospitals
5.5.3.2. Cardiac Catheterization Laboratories
5.5.3.3. Ambulatory Surgical Centers
5.5.3.4. Others
5.6. Market Attractiveness Analysis: End User
6. Global Pulmonary Embolism Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2018 - 2022
6.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2023 - 2031
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia and Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Pulmonary Embolism Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
7.1. Key Highlights
7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
7.2.1. By Country
7.2.2. By Product
7.2.3. By End User
7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
7.3.1. U.S.
7.3.2. Canada
7.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2023 - 2031
7.4.1. Catheter-Directed Thrombolysis Devices
7.4.2. Mechanical Thrombectomy Devices
7.4.2.1. Thrombus Fragmentation Devices
7.4.2.2. Aspiration Thrombectomy Devices
7.4.2.3. Rheolytic Thrombectomy Devices
7.4.2.4. Others
7.4.3. Others
7.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
7.5.1. Hospitals
7.5.2. Cardiac Catheterization Laboratories
7.5.3. Ambulatory Surgical Centers
7.5.4. Others
7.6. Market Attractiveness Analysis
8. Europe Pulmonary Embolism Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
8.1. Key Highlights
8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
8.2.1. By Country
8.2.2. By Product
8.2.3. By End User
8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Russia
8.3.7. Türkiye
8.3.8. Rest of Europe
8.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2023 - 2031
8.4.1. Catheter-Directed Thrombolysis Devices
8.4.2. Mechanical Thrombectomy Devices
8.4.2.1. Thrombus Fragmentation Devices
8.4.2.2. Aspiration Thrombectomy Devices
8.4.2.3. Rheolytic Thrombectomy Devices
8.4.2.4. Others
8.4.3. Others
8.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
8.5.1. Hospitals
8.5.2. Cardiac Catheterization Laboratories
8.5.3. Ambulatory Surgical Centers
8.5.4. Others
8.6. Market Attractiveness Analysis
9. East Asia Pulmonary Embolism Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
9.1. Key Highlights
9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
9.2.1. By Country
9.2.2. By Product
9.2.3. By End User
9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
9.3.1. China
9.3.2. Japan
9.3.3. South Korea
9.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2023 - 2031
9.4.1. Catheter-Directed Thrombolysis Devices
9.4.2. Mechanical Thrombectomy Devices
9.4.2.1. Thrombus Fragmentation Devices
9.4.2.2. Aspiration Thrombectomy Devices
9.4.2.3. Rheolytic Thrombectomy Devices
9.4.2.4. Others
9.4.3. Others
9.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
9.5.1. Hospitals
9.5.2. Cardiac Catheterization Laboratories
9.5.3. Ambulatory Surgical Centers
9.5.4. Others
9.6. Market Attractiveness Analysis
10. South Asia & Oceania Pulmonary Embolism Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
10.1. Key Highlights
10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
10.2.1. By Country
10.2.2. By Product
10.2.3. By End User
10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
10.3.1. India
10.3.2. Southeast Asia
10.3.3. ANZ
10.3.4. Rest of South Asia & Oceania
10.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2023 - 2031
10.4.1. Catheter-Directed Thrombolysis Devices
10.4.2. Mechanical Thrombectomy Devices
10.4.2.1. Thrombus Fragmentation Devices
10.4.2.2. Aspiration Thrombectomy Devices
10.4.2.3. Rheolytic Thrombectomy Devices
10.4.2.4. Others
10.4.3. Others
10.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
10.5.1. Hospitals
10.5.2. Cardiac Catheterization Laboratories
10.5.3. Ambulatory Surgical Centers
10.5.4. Others
10.6. Market Attractiveness Analysis
11. Latin America Pulmonary Embolism Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
11.1. Key Highlights
11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
11.2.1. By Country
11.2.2. By Product
11.2.3. By End User
11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2023 - 2031
11.4.1. Catheter-Directed Thrombolysis Devices
11.4.2. Mechanical Thrombectomy Devices
11.4.2.1. Thrombus Fragmentation Devices
11.4.2.2. Aspiration Thrombectomy Devices
11.4.2.3. Rheolytic Thrombectomy Devices
11.4.2.4. Others
11.4.3. Others
11.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
11.5.1. Hospitals
11.5.2. Cardiac Catheterization Laboratories
11.5.3. Ambulatory Surgical Centers
11.5.4. Others
11.6. Market Attractiveness Analysis
12. Middle East & Africa Pulmonary Embolism Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
12.1. Key Highlights
12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
12.2.1. By Country
12.2.2. By Product
12.2.3. By End User
12.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
12.3.1. GCC Countries
12.3.2. Egypt
12.3.3. South Africa
12.3.4. Northern Africa
12.3.5. Rest of Middle East & Africa
12.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2023 - 2031
12.4.1. Catheter-Directed Thrombolysis Devices
12.4.2. Mechanical Thrombectomy Devices
12.4.2.1. Thrombus Fragmentation Devices
12.4.2.2. Aspiration Thrombectomy Devices
12.4.2.3. Rheolytic Thrombectomy Devices
12.4.2.4. Others
12.4.3. Others
12.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
12.5.1. Hospitals
12.5.2. Cardiac Catheterization Laboratories
12.5.3. Ambulatory Surgical Centers
12.5.4. Others
12.6. Market Attractiveness Analysis
13. Competition Landscape
13.1. Market Share Analysis, 2023
13.2. Market Structure
13.2.1. Competition Intensity Mapping By Market
13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
13.3.1. Inari Medical, Inc.
13.3.1.1. Overview
13.3.1.2. Segments and Products
13.3.1.3. Key Financials
13.3.1.4. Market Developments
13.3.1.5. Market Strategy
13.3.2. Penumbra, Inc.
13.3.2.1. Overview
13.3.2.2. Segments and Products
13.3.2.3. Key Financials
13.3.2.4. Market Developments
13.3.2.5. Market Strategy
13.3.3. Akura Medical, Inc. (Shifamed, LLC.)
13.3.3.1. Overview
13.3.3.2. Segments and Products
13.3.3.3. Key Financials
13.3.3.4. Market Developments
13.3.3.5. Market Strategy
13.3.4. Boston Scientific Corporation
13.3.4.1. Overview
13.3.4.2. Segments and Products
13.3.4.3. Key Financials
13.3.4.4. Market Developments
13.3.4.5. Market Strategy
13.3.5. Thrombolex, Inc.
13.3.5.1. Overview
13.3.5.2. Segments and Products
13.3.5.3. Key Financials
13.3.5.4. Market Developments
13.3.5.5. Market Strategy
13.3.6. AngioDynamics
13.3.6.1. Overview
13.3.6.2. Segments and Products
13.3.6.3. Key Financials
13.3.6.4. Market Developments
13.3.6.5. Market Strategy
13.3.7. Straub Medical
13.3.7.1. Overview
13.3.7.2. Segments and Products
13.3.7.3. Key Financials
13.3.7.4. Market Developments
13.3.7.5. Market Strategy
13.3.8. Cook Medical Inc.
13.3.8.1. Overview
13.3.8.2. Segments and Products
13.3.8.3. Key Financials
13.3.8.4. Market Developments
13.3.8.5. Market Strategy
13.3.9. Edward Lifesciences Corporation
13.3.9.1. Overview
13.3.9.2. Segments and Products
13.3.9.3. Key Financials
13.3.9.4. Market Developments
13.3.9.5. Market Strategy
13.3.10. Rex Medical
13.3.10.1. Overview
13.3.10.2. Segments and Products
13.3.10.3. Key Financials
13.3.10.4. Market Developments
13.3.10.5. Market Strategy
13.3.11. Medtronic
13.3.11.1. Overview
13.3.11.2. Segments and Products
13.3.11.3. Key Financials
13.3.11.4. Market Developments
13.3.11.5. Market Strategy
13.3.12. Merit Medical
13.3.12.1. Overview
13.3.12.2. Segments and Products
13.3.12.3. Key Financials
13.3.12.4. Market Developments
13.3.12.5. Market Strategy
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations